ResMed - 24 Year Stock Price History | RMD

Historical daily share price chart and data for ResMed since 1995 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for ResMed as of January 18, 2019 is 117.84.
ResMed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 113.7931 111.7700 117.8400 106.4800 117.8400 3.49%
2018 102.7844 84.6130 115.5500 84.6130 113.8700 35.91%
2017 73.5447 60.1489 85.5132 60.0712 83.7820 39.07%
2016 58.5286 49.6416 67.9001 48.8714 60.2460 18.02%
2015 55.9630 53.2843 70.0408 46.7548 51.0488 -2.30%
2014 45.6304 42.1592 53.4893 38.3539 52.2497 21.62%
2013 43.1829 38.1020 51.8610 38.1020 42.9623 15.22%
2012 30.5781 22.7705 38.3621 22.0592 37.2858 65.10%
2011 26.7604 31.1372 31.3684 20.8589 22.5838 -26.67%
2010 27.8984 23.4685 31.6618 22.4727 30.7993 32.54%
2009 18.8166 17.0623 23.5930 14.1460 23.2373 39.46%
2008 17.9791 22.8105 22.8105 13.2613 16.6622 -28.65%
2007 20.1763 22.2593 24.1220 17.6269 23.3529 6.72%
2006 19.3299 16.9912 22.7083 16.3866 21.8814 28.48%
2005 14.8314 11.2941 18.9917 11.0718 17.0312 49.94%
2004 10.5616 9.3358 11.4608 9.0446 11.3586 23.01%
2003 8.5156 6.9018 10.3339 6.5951 9.2336 35.89%
2002 7.4442 11.8143 11.8143 5.4904 6.7951 -43.31%
2001 11.1249 8.7534 13.7259 8.1488 11.9854 35.21%
2000 6.8685 4.5434 9.2247 4.5223 8.8646 91.04%
1999 3.7102 4.7513 5.7171 2.1950 4.6401 -8.00%
1998 2.5000 1.5560 5.2514 1.5560 5.0436 222.77%
1997 1.3115 1.1948 1.7227 0.9447 1.5626 27.82%
1996 0.8971 0.6668 1.2781 0.5835 1.2225 69.23%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.792B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $125.437B 25.42
Medtronic (MDT) Ireland $117.248B 17.53
Stryker (SYK) United States $62.695B 23.63
Boston Scientific (BSX) United States $52.155B 26.36
Baxter (BAX) United States $37.585B 24.27
Zimmer Biomet Holdings (ZBH) United States $21.487B 13.93
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
Canopy Growth (CGC) Canada $10.104B 0.00
Bio-Rad Laboratories (BIO) United States $7.180B 45.91
Hill-Rom Holdings (HRC) United States $6.608B 20.68
Aurora Cannabis (ACB) Canada $6.428B 33.89
Perrigo (PRGO) Ireland $6.245B 9.48
Haemonetics (HAE) United States $5.216B 45.87
ICU Medical (ICUI) United States $4.878B 27.18
Insulet (PODD) United States $4.428B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.141B 0.00
Agios Pharmaceuticals (AGIO) United States $3.252B 0.00
Neogen (NEOG) United States $3.150B 48.38
Hutchison China MediTech (HCM) China $2.945B 0.00
National Vision Holdings (EYE) United States $2.566B 49.63
NuVasive (NUVA) United States $2.469B 22.98
Quidel (QDEL) United States $2.084B 27.17
NxStage Medical (NXTM) United States $1.901B 0.00
Aphria (APHA) $1.668B 74.22
Phibro Animal Health (PAHC) United States $1.294B 18.32
AtriCure (ATRC) United States $1.222B 0.00
VAREX IMAGING (VREX) United States $1.060B 21.23
Cardiovascular Systems (CSII) United States $1.013B 1457.00
PetIQ (PETQ) United States $0.781B 20.25
Cerus (CERS) United States $0.771B 0.00
OraSure Technologies (OSUR) United States $0.747B 42.03
Meridian Bioscience (VIVO) United States $0.713B 22.73
Eagle Pharmaceuticals (EGRX) United States $0.662B 21.24
Omeros (OMER) United States $0.658B 0.00
Surmodics (SRDX) United States $0.642B 97.18
Lantheus Holdings (LNTH) United States $0.637B 19.73
NanoString Technologies (NSTG) United States $0.624B 0.00
MacroGenics (MGNX) United States $0.520B 0.00
Quanterix (QTRX) United States $0.467B 0.00
LeMaitre Vascular (LMAT) United States $0.458B 22.48
Owens & Minor (OMI) United States $0.453B 5.12
Evolus (EOLS) United States $0.436B 0.00
TG Therapeutics (TGTX) United States $0.375B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.85
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.279B 0.00
Bovie Medical (APYX) United States $0.278B 0.00
Vapotherm (VAPO) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.244B 0.00
BioLife Solutions (BLFS) United States $0.226B 305.00
Rockwell Medical (RMTI) United States $0.198B 0.00
Fonar (FONR) United States $0.139B 7.00
Chimerix (CMRX) United States $0.137B 0.00
Surface Oncology (SURF) United States $0.136B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
United-Guardian (UG) United States $0.090B 18.85
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 18.07
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.031B 0.00
Myomo (MYO) United States $0.022B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00